CB1001 is a patient with high-risk disease that includes a clonal MYCN amplification, and for whom 5 SCNA profiles were available comprising 4 regions from the primary tumour and 1 from a metastatic renal infiltration. This evidence concerns the gene MYCN and neoplasm.